• LAST PRICE
    1.3700
  • TODAY'S CHANGE (%)
    Trending Up0.0500 (3.7879%)
  • Bid / Lots
    1.3100/ 120
  • Ask / Lots
    1.7000/ 8
  • Open / Previous Close
    1.3200 / 1.3200
  • Day Range
    Low 1.2920
    High 1.4800
  • 52 Week Range
    Low 1.1000
    High 4.6500
  • Volume
    328,434
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.32
TimeVolumeGBIO
09:32 ET11821.32
09:35 ET1441.32
09:42 ET2001.3
10:02 ET1111.335
10:04 ET9071.395
10:06 ET1071.3823
10:08 ET5751.385
10:11 ET10221.375
10:15 ET4291.38
10:22 ET30001.355
10:24 ET3001.33
10:26 ET1381.33
10:29 ET3001.305
10:31 ET15021.3043
10:33 ET116061.3
10:36 ET45291.3
10:38 ET2001.31
10:40 ET35451.315
10:42 ET2401.31
10:44 ET70361.315
10:47 ET30001.3284
10:49 ET125001.35
10:51 ET196211.38
10:54 ET163491.3699
10:56 ET58311.37
10:58 ET18421.361
11:00 ET4001.37
11:02 ET21991.373
11:03 ET215681.4
11:05 ET8951.39
11:09 ET10321.39
11:12 ET1001.39
11:14 ET112041.42
11:16 ET10001.42
11:18 ET106501.4116
11:20 ET3001.425
11:21 ET25001.42
11:23 ET19251.42
11:25 ET2001.42
11:30 ET1201.415
11:36 ET12961.43
11:38 ET12001.43
11:41 ET1001.43
11:43 ET27091.42
11:45 ET5951.421
11:50 ET1001.43
11:52 ET1101.4299
11:54 ET2001.42
11:56 ET5001.42
11:59 ET1281.425
12:01 ET3001.425
12:06 ET35371.44
12:12 ET1001.44
12:15 ET10361.44
12:17 ET1381.44
12:21 ET35001.45
12:26 ET5001.4698
12:28 ET41561.47
12:30 ET1001.48
12:32 ET6001.475
12:35 ET21071.465
12:42 ET20501.44
12:48 ET30001.44
12:51 ET5001.44
12:53 ET23941.43
01:00 ET10001.4286
01:09 ET20081.41
01:11 ET9351.41
01:13 ET6451.41
01:15 ET2001.41
01:18 ET4371.41
01:26 ET1001.41
01:27 ET8501.4018
01:31 ET1001.4
01:33 ET4001.41
01:36 ET1701.4134
01:38 ET11591.4008
01:40 ET5631.41
01:42 ET2001.4
01:45 ET65451.39
01:47 ET2001.38
01:49 ET44001.365
01:51 ET1001.37
01:56 ET1081.37
02:00 ET19501.375
02:02 ET16071.3733
02:07 ET1451.3798
02:09 ET15001.375
02:12 ET21141.38
02:14 ET12831.39
02:18 ET1001.39
02:20 ET3501.39
02:23 ET1001.39
02:25 ET12111.39
02:30 ET2001.395
02:34 ET5251.395
02:36 ET6001.395
02:38 ET22291.4
02:39 ET2391.4
02:41 ET3661.4
02:43 ET7691.38
02:45 ET8001.37
02:52 ET1001.36
02:54 ET1001.37
02:56 ET4641.38
02:57 ET1091.375
03:01 ET68001.36
03:03 ET1001.36
03:06 ET10661.36
03:08 ET21001.36
03:10 ET1001.36
03:12 ET1511.36
03:15 ET16001.36
03:17 ET5081.36
03:19 ET1001.36
03:21 ET10571.35
03:24 ET87241.345
03:26 ET14051.345
03:28 ET2501.3422
03:30 ET4001.34
03:32 ET11001.35
03:33 ET40501.3599
03:35 ET3001.355
03:37 ET2001.355
03:39 ET4001.35
03:42 ET37171.36
03:44 ET2001.36
03:46 ET1001.37
03:48 ET31301.365
03:50 ET4411.37
03:51 ET17001.3699
03:53 ET1001.365
03:55 ET36031.375
03:57 ET36731.37
04:00 ET305831.37
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGBIO
Generation Bio Co
91.5M
-0.6x
---
United StatesANL
Adlai Nortye Ltd
97.0M
-0.4x
---
United StatesASMB
Assembly Biosciences Inc
95.6M
-2.0x
---
United StatesCOYA
Coya Therapeutics Inc
108.6M
-9.4x
---
United StatesARMP
Armata Pharmaceuticals Inc
81.4M
-1.8x
---
United StatesCRVO
CervoMed Inc
79.2M
-6.0x
---
As of 2024-11-23

Company Information

Generation Bio Co. is a biotechnology company. The Company is innovating non-viral genetic medicines to provide durable, redosable treatments for hundreds of millions of patients living with rare and prevalent diseases. The Company is developing two distinct and complementary platforms: a potent, highly selective cell-targeted lipid nanoparticle (ctLNP) delivery system and a novel immune-quiet DNA (iqDNA) cargo produced by a scalable capsid-free manufacturing process that uses proprietary cell-free rapid enzymatic synthesis (RES). The Company is advancing a portfolio of programs guided by the potent and highly selective delivery of messenger ribonucleic acid (mRNA) and/or iqDNA using its ctLNP delivery system to target T cells, hematopoietic stem cells (HSCs), and hepatocytes, and intend to expand to additional tissues and cell types. Its work in T cells focuses on in vivo reprogramming of this cell type to treat cancer and autoimmune diseases.

Contact Information

Headquarters
301 BINNEY STREETCAMBRIDGE, MA, United States 02142
Phone
857-529-5908
Fax
302-655-5049

Executives

Independent Chairman of the Board
Jason Rhodes
President, Chief Executive Officer, Director
Cameron Mcdonough
Chief Financial Officer
Matthew Norkunas
Chief Operating Officer
Antoinette Paone
Chief Scientific Officer
Matthew Stanton

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$91.5M
Revenue (TTM)
$18.6M
Shares Outstanding
66.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.69
EPS
$-2.19
Book Value
$3.07
P/E Ratio
-0.6x
Price/Sales (TTM)
4.9
Price/Cash Flow (TTM)
---
Operating Margin
-846.24%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.